On March 8, 2018 Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, reported that Ivan Bergstein, M.D., Stemline’s CEO, will present at two upcoming investor conferences (Press release, Stemline Therapeutics, MAR 8, 2018, View Source [SID1234524545]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 30th Annual ROTH Conference on Monday, March 12, at 4:00 PM PT (7:00 PM ET), which is being held at The Ritz-Carlton, Orange County in Dana Point, California.

The Cowen and Company 38th Annual Health Care Conference 2018 on Wednesday, March 14, at 8:00 AM ET, which is being held at the Boston Marriott Copley Place in Boston, MA.
A live webcast of each presentation can be viewed on the company’s website at www.stemline.com.